0.2520
22-11月-24 16:44:58
15 分の遅延
株式
-0.0040
-1.56%
本日の幅
0.2435 - 0.2684
ISIN
N/A
ソース
NASDAQ
Vincerx Pharma Presents Data on PTEFb/CDK9 Inhibitor VIP152 in DLBCL and CLL at the 63rd American Society of Hematology Annual Meeting
11 12 2021 15:30:00 提供 Nasdaq GlobeNewswire
Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma
07 12 2021 08:00:01 提供 Nasdaq GlobeNewswire